Holen Sie sich die Stockscreener-App
2.815
0.53%
0.015
Finanzdaten der Moleculin Biotech Inc-Aktie (MBRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
25.14%
6.677
|
8.919 | 5.947 | 6.411 | 8.354 |
| Operating Income/Loss |
25.14%
-6.677
|
-8.919 | -5.947 | -6.411 | -8.354 |
| Income/Loss From Continuing Operations Before Tax |
51.60%
-4.97
|
-10.27 | -5.609 | -5.976 | -7.915 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
51.60%
-4.97
|
-10.27 | -5.609 | -5.976 | -7.915 |
|
Net Income/Loss
|
51.60%
-4.97
|
-10.27 | -5.609 | -5.976 | -7.915 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
108.99%
2.4662
|
-27.44 | 29.81 | 29.69 | 28.75 |
| Basic Earnings Per Share |
85.98%
-2.02
|
-14.41 | -0.19 | -0.20 | -0.28 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.23%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):